Preventative Treatment for Migraine Patients

CE / CME

Personalized Migraine Prevention: Crafting Proactive Treatment Plans through Shared Decision-Making

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Pharmacists: 0.50 contact hour (0.05 CEUs)

Released: May 28, 2024

Expiration: May 27, 2025

Nada Hindiyeh
Nada Hindiyeh, MD, FAHS

Activity

Progress
1 2
Course Completed

  1. Lipton RB, Nicholson RA, Reed ML, et al. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study. Headache. 2022;62:122-140.
  2. Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17:501-514.
  3. Ailani J, Burch RC, Robbins MS, Board of Directors of the American Headache Society. The American Headache Society consensus statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61:1021-1039.
  4. US Food and Drug Administration. Approval package. accessdata.fda.gov/drugsatfda_docs/bla/2010/103000orig1s5215.pdf. Accessed April 22, 2024.
  5. Mavridis T, Deligianni CI, Karagiorgis G, et al. Monoclonal antibodies targeting CGRP: From clinical studies to real-world evidence-what do we know so far? Pharmaceuticals (Basel). 2021;14.
  6. Rissardo JP, Caprara ALF. Gepants for acute and preventive migraine treatment: A narrative review. Brain Sci. 2022;12.
  7. Charles AC, Digre KB, Goadsby PJ, et al. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache. 2024;64:333-341.
  8. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211.
  9. OnabotulinumtoxinA [prescribing information]. Madison, NJ: Allergan USA, Inc; 2023.
  10. Atogepant [prescribing information]. Dublin, Ireland: Forest Laboratories Ireland Ltd; 2023.
  11. Eptinezumab-jjmr [prescribing information]. Bothell, WA: Lundbeck Seattle BioPharmaceuticals, Inc. ; 2022.
  12. Rizatriptan benzoate [prescribing information]. Whitehouse Station, NJ: Merck & Co, Inc.; 2019.
  13. Zavegepant [prescribing information]. New York, NY: Pfizer Labs; 2023.